Centessa Pharmaceuticals (CNTA) Interest Coverage Ratio (2022 - 2026)
Centessa Pharmaceuticals (CNTA) reported Interest Coverage Ratio of 29.21 for Q1 2026, down 173.05% year-over-year from 39.98 in Q1 2025, and down 19.79% quarter-over-quarter from 24.38 in Q4 2025.
Centessa Pharmaceuticals (CNTA) Interest Coverage Ratio (2022 - 2026) Analysis & Trends
Centessa Pharmaceuticals (CNTA) has 5 years of Interest Coverage Ratio data on file, last reported at 29.21 in Q1 2026.
- Interest Coverage Ratio for Q1 2026 came in at 29.21, down 173.05% year-over-year; the trailing twelve-month figure through Mar 2026 was 22.69 (down 20.99% YoY), and the FY2025 annual result was 18.12, up 9.04% from the prior year.
- Interest Coverage Ratio slipped to 29.21 in Q1 2026 per CNTA's latest filing, from 24.38 in the prior quarter.
- Over five years, Interest Coverage Ratio peaked at 10.7 in Q1 2025 and troughed at 41.39 in Q2 2022.
- A 5-year average of 21.92 and a median of 18.95 in 2025 frame the typical range for Interest Coverage Ratio.
- The sharpest annual moves came in 2023 and 2026: Interest Coverage Ratio soared 53.63% in 2023, then sank 173.05% in 2026.
- A 5-year view of Interest Coverage Ratio shows it stood at 18.88 in 2022, then climbed by 27.52% to 13.69 in 2023, then slumped by 119.79% to 30.08 in 2024, then increased by 18.95% to 24.38 in 2025, then fell by 19.79% to 29.21 in 2026.
- Business Quant data shows CNTA's Interest Coverage Ratio at 29.21 in Q1 2026, 24.38 in Q4 2025, and 18.61 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 3.58 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 11.50 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -258.33 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 547.67 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 11.79 |
| 10 | Centessa Pharmaceuticals | 6.15 Bn | 6.15 Bn | - | -29.21 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -29.21 |
| Dec 31, 2025 | -24.38 |
| Sep 30, 2025 | -18.61 |
| Jun 30, 2025 | -18.95 |
| Mar 31, 2025 | -10.70 |
| Dec 31, 2024 | -30.08 |
| Sep 30, 2024 | -18.15 |
| Jun 30, 2024 | -17.42 |
| Mar 31, 2024 | -14.27 |
| Dec 31, 2023 | -13.69 |
| Sep 30, 2023 | -15.82 |
| Jun 30, 2023 | -19.19 |
| Mar 31, 2023 | -20.84 |
| Dec 31, 2022 | -18.88 |
| Sep 30, 2022 | -25.51 |
| Jun 30, 2022 | -41.39 |
| Mar 31, 2022 | -35.48 |